RMEAX — Aspiriant Risk-Managed Equity Allocation Fund
Data updated: 2026-06-11
RMEAX — Aspiriant Risk-Managed Equity Allocation Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. Hedged · $1.28B AUM · 1.24% expense ratio · 11.9% 1-yr return. From SEC regulatory filings.
RMEAX Fund Overview
RMEAX — Aspiriant Risk-Managed Equity Allocation Fund is a US mutual fund managed by Aspiriant Trust, categorised as Hedged. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Aspiriant Trust
- Category: Hedged
- Assets under management: $1.28B
- 1-year return: 11.9%
- Ticker: RMEAX
- SEC CIK: 0001534881
- SEC series ID: S000036290
- Share class ID: C000111026
RMEAX Holdings
Top 10 holdings of Aspiriant Risk-Managed Equity Allocation Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| GMO Quality Fund | 33.34% |
| Schwab Fundamental Emerging Markets Equity ETF | 7.63% |
| Rief Strategic Partners Fund | 7.15% |
| Baillie Gifford Emerging Markets Equities Fund | 5.01% |
| GMO Investments ICAV - GMO Equity Dislocation Investment Fund | 4.78% |
| AQR Large Cap Defensive Style Fund | 4.04% |
| Viking Global Equities LP | 3.91% |
| JPMorgan Prime Money Market Fund | 3.43% |
| iShares MSCI Global Min Vol Factor ETF | 3.11% |
| iShares MSCI ACWI ETF | 2.32% |
RMEAX Portfolio Allocation
Asset-class allocation of Aspiriant Risk-Managed Equity Allocation Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Other | 71.3% |
| Equity | 25.2% |
| Cash & Equivalents | 4.5% |
RMEAX Performance
Total returns for RMEAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -3.4% |
| 1 year | 11.9% |
| 3 years (annualised) | 13.2% |
| 5 years (annualised) | 7.7% |
RMEAX Risk Information
Risk metrics for RMEAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 8.9%
RMEAX Costs and Fees
RMEAX costs about $124 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.24%
- Gross expense ratio: 1.37%
- Portfolio turnover: 19%
- Brokerage commissions: 1.10 bps of average net assets (SEC N-CEN)
RMEAX Cashflows
Over the 12 months to 2026-03, Aspiriant Risk-Managed Equity Allocation Fund had net outflows of $14.17M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$2.31M |
| 2026-02 | −$334.00K |
| 2026-01 | $34.33M |
| 2025-12 | −$767.79K |
| 2025-11 | −$7.39M |
| 2025-10 | −$11.33M |
RMEAX Debt Constituents
No individual debt constituents are reported in Aspiriant Risk-Managed Equity Allocation Fund's latest SEC N-PORT filing.
RMEAX Prospectus and SEC Filings
Official Aspiriant Risk-Managed Equity Allocation Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other Hedged funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.